Skip to main content
Premium Trial:

Request an Annual Quote

Amersham to Distribute Gene Logic s Products in Japan

NEW YORK, Sept 26 – Gene Logic (Nasdaq: GLGC) said Tuesday it had reached a deal that would give Amersham Pharmacia Biotech K.K. the exclusive rights to market sell Gene Logic’s products in Japan.

Under the terms of the deal, Amersham Pharmacia Biotech K.K, the Japanese subsidiary of Amersham Pharmacia Biotech, will market and sell Gene Logic’s range of databases and software tools to Japanese pharmaceutical and biotech companies.

Financial terms of the agreement were not disclosed.

“This alliance fits with Amersham Pharmacia Biotech K.K.'s business strategy and will help further strengthen our position in the genomics market in Japan," Kazuo Takeuchi, vice president at Amersham Pharmacia Biotech K.K., said in a statement.

Mark Gessler, president and CEO of Gene Logic, said the deal reflected the company’s efforts to expand its marketing reach overseas.

Amersham Pharmacia Biotech, is the life sciences division of Nycomed Amersham (London: NAM; NYSE: NYE).

Gene Logic, of Gaithersburg, Md., has developed a database that contains information about gene expression in human and animal tissues.

Shares of Gene Logic were down 3/4, or 3.6 percent, at 201/4 in afternoon trading.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.